Answers are grounded in this paper and cite their sources.
Four days after a single dose of teflutixol (5 mg/kg i.p.), at which time mice are superresponsive to dopamine agonists, e.g. apomorphine, the specific binding of [ 3 H]haloperidol, [ 3 H]cis (Z)‐flupenthixol, [ 3 H]apomorphine, [ 3 H]dopamine, [ 3 H]propylbenzilylcholine mustard and [ 3 H]GABA to striatal membranes in vitro is equal to that of saline‐treated mice. Specific binding of [ 3 H]haloperidol is also unchanged 3 days following a single dose of fluphenazine (5mg/kg i.p.) and 2 days following haloperidol (5 mg/kg i.p.), but slightly decreased 3 days following cis(Z)‐flupenthixol (5 mg/kg i.p.). The possibility that remaining neuroleptic or active metabolites could obscure a slight increase in dopamine receptor binding was rejected, since remaining amounts of [ 3 H]teflutixol in the final binding assay 4 days after intraperitoneal injection of [ 3 H]teflutixol (5 mg/kg) were too small to influence the binding of [ 3 H]haloperidol in vitro . It is concluded that the pharmacological superresponsiveness and the decrease in dopamine synthesis and release seen after the initial receptor blockade following a single dose of neuroleptic drugs in mice are nor accompanied by changes in dopamine, muscarine or GABAergic receptor characteristics in corpus striatum. The possibility that changes occur in a small number of functional operative dopamine receptors cannot be excluded, however.
No takes yet. Share an insight, caveat, or question.
John Hyttel (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: